Ceidos SA

Biopharmaceuticals are medicines that are produced by cells in culture, including cell therapies, gene therapies, monoclonal antibodies, proteins and even vaccines. They are revolutionizing medicine, providing treatment against cancers, degenerative diseases and genetic disorders.

The production of these treatments requires highly controlled manufacturing methods, during the whole process. In this context, Ceidos develops the C-Netics to fully automate cell expansion monitoring in a closed system. This ensures better outcomes and reduces the process’ costs as contamination risk is prevented and manual handling is drastically reduced. This makes innovative medical therapies accessible to the greatest number of patients.